We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,493 results
  1. De novo normotensive scleroderma renal crisis six years after living-donor renal transplantation in a patient with overlap** systemic sclerosis/systemic lupus erythematosus syndrome: a case report

    Background

    Scleroderma renal crisis (SRC) is a critical kidney involvement of systemic sclerosis (SSc), often resulting in end-stage renal disease....

    Hajime Sanada, Satoshi Hara, ... Mitsuhiro Kawano in BMC Nephrology
    Article Open access 04 December 2023
  2. De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease

    A 63-year-old man with polycystic kidney disease underwent kidney transplantation from his wife. Nine years later, after the first and second doses...

    Miruzato Fukuda, Takayoshi Yokoyama, ... Yoshifumi Ubara in CEN Case Reports
    Article 23 March 2024
  3. Managing Lupus Nephritis in Children and Adolescents

    Lupus nephritis is an important manifestation of systemic lupus erythematosus, which leads to chronic kidney disease, kidney failure, and can result...

    Eugene Yu-hin Chan, Fiona Fung-yee Lai, ... Tak Mao Chan in Pediatric Drugs
    Article 20 December 2023
  4. Drug-induced de novo thrombotic microangiopathy diagnosed 2 years after renal transplantation: a case report and literature review

    Background

    Post-transplant de novo thrombotic microangiopathy (TMA) is a rare yet serious complication that generally can develop in renal transplant...

    Keisuke Ozaki, Tomoya Fukawa, ... Hiro-omi Kanayama in Renal Replacement Therapy
    Article Open access 04 January 2023
  5. A case of acute tubulointerstitial nephritis following administration of the Oxford-AstraZeneca COVID-19 vaccine: a case report

    Background

    More than 4 billion doses of the Coronavirus disease (COVID-19) vaccine have been administered worldwide but the relationship between the...

    Samuel B. M. Williams, Stephen D. J. Holwill, ... Coralie Bingham in BMC Nephrology
    Article Open access 14 March 2023
  6. Karyomegalic interstitial nephritis as a rare cause of kidney graft dysfunction: case report and review of literature

    Karyomegalic interstitial nephritis (KIN) is a rare cause of chronic interstitial nephritis characterized by enlarged renal tubular epithelial...

    Fatma El-Husseiny Moustafa, Eman Nagy, ... Mohamed Sobh in BMC Nephrology
    Article Open access 19 May 2023
  7. De novo lupus-like glomerulonephritis after pediatric non-kidney organ transplantation

    Background

    We propose a novel clinically significant finding, de novo lupus-like glomerulonephritis (DNLLGN), in patients with autoantibodies and...

    Cristina M. Farkas-Skiles, Robert B. Ettenger, ... Patricia L. Weng in Pediatric Nephrology
    Article Open access 22 July 2021
  8. Clinical characteristics of renal transplant recipients who developed de novo donor-specific antigen in Kyoto University Hospital: a case series

    Background

    The clinical significance of de novo donor-specific antigen (DSA) in renal transplant recipients is not yet fully understood. This study...

    Kenji Nakamura, Atsuro Sawada, ... Takashi Kobayashi in Renal Replacement Therapy
    Article Open access 01 April 2022
  9. Mycophenolate-induced colitis in a patient with lupus nephritis: a case report and review of the literature

    Background

    Mycophenolate mofetil (MMF) is an immunosuppressive drug that is frequently prescribed to patients with rheumatological diseases. MMF’s...

    Ziyad Alakkas, Abdulaziz M. Gari, ... Eman A. AlSindi in Journal of Medical Case Reports
    Article Open access 01 May 2024
  10. Lupus Nephritis: Improving Treatment Options

    Despite improvements in patient and renal death rates following the introduction of potent immunosuppressive drugs in earlier decades, a sizeable...

    Myrto Kostopoulou, Sofia Pitsigavdaki, George Bertsias in Drugs
    Article 29 April 2022
  11. Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network

    Background

    Leveraging the Accelerating Medicines Partnership (AMP) Lupus Nephritis (LN) dataset, we evaluated longitudinal patterns, rates, and...

    Peter M. Izmirly, Mimi Y. Kim, ... Richard Furie in Arthritis Research & Therapy
    Article Open access 20 February 2024
  12. Fetal and maternal outcome in patients with active lupus nephritis: comparison between new-onset and pre-existing lupus nephritis

    Background

    This study aimed to investigate fetal and maternal outcomes in women with active lupus nephritis (LN). Specifically, we compared women who...

    **ng-Ji Lian, Li Fan, ... Wei Chen in BMC Nephrology
    Article Open access 21 December 2021
  13. Leflunomide therapy for IgA vasculitis with nephritis in children

    Background

    Henoch-Schönlein purpura (HSP), also called IgA vasculitis, is a systemic vasculitis characterized by deposits of immunoglobulin A in blood...

    Ling Hou, Zhou Zhang, Yue Du in BMC Pediatrics
    Article Open access 08 September 2021
  14. Biopsy findings after detection of de novo donor-specific antibodies in renal transplant recipients: a single center experience

    Background

    De novo donor-specific antibodies (DSA) are associated with an increased risk of antibody-mediated rejection and a substantial reduction of...

    Christoph B. Waldecker, Panagiota Zgoura, ... Timm H. Westhoff in Journal of Nephrology
    Article Open access 17 April 2021
  15. Effect of Paclitaxel-Coated Balloon Angioplasty on Side Branch Lesion and Cardiovascular Outcomes in Patients with De Novo True Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention

    Purpose

    To compare the effects of paclitaxal-coated balloon (PCB) versus conventional balloon (CB) on side branch (SB) lesion and cardiovascular...

    Youmei Li, Qi Mao, ... Jianhua Zhao in Cardiovascular Drugs and Therapy
    Article 09 July 2021
  16. AURORA 1 reports efficacy of voclosporin in lupus nephritis

    Gabriella Moroni, Claudio Ponticelli in Nature Reviews Nephrology
    Article 01 July 2021
  17. 45/w mit zunehmender Proteinurie

    Eleni Evangelidou in Die Nephrologie
    Article 11 July 2024
  18. Henoch–schonlein purpura following exposure to SARS-CoV2 vaccine or infection: a systematic review and a case report

    Background

    Henoch–Schonlein purpura (HSP) is an IgA-mediated systemic small-vessel vasculitis (IgAV) that typically presents with a variable tetrad of...

    Federica Di Vincenzo, Sara Ennas, ... Giovanni Cammarota in Internal and Emergency Medicine
    Article Open access 27 July 2023
  19. Therapy-related MDS dissected based on primary disease and treatment—a nationwide perspective

    In this population-based study, we aimed to characterize and compare subgroups of therapy-related Myelodysplastic syndromes (t-MDS) and define the...

    Daniel Moreno Berggren, Hege Garelius, ... Elisabeth Ejerblad in Leukemia
    Article Open access 17 March 2023
Did you find what you were looking for? Share feedback.